Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
61
NMPA:61
Drug Approvals
Sevelamer Carbonate for Suspension
- Product Name
- 碳酸司维拉姆干混悬剂
- Approval Number
- 国药准字H20253566
- Approval Date
- Mar 4, 2025
NMPA
Sevelamer Carbonate for Suspension
- Product Name
- 碳酸司维拉姆干混悬剂
- Approval Number
- 国药准字H20244815
- Approval Date
- Sep 3, 2024
NMPA
Ropinirole Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸罗匹尼罗缓释片
- Approval Number
- 国药准字H20244677
- Approval Date
- Aug 20, 2024
NMPA
Avatrombopag Maleate Tablets
- Product Name
- 马来酸阿伐曲泊帕片
- Approval Number
- 国药准字H20244403
- Approval Date
- Jul 9, 2024
NMPA
Trimetazidine Hydrochloride Tablets
- Product Name
- 盐酸曲美他嗪片
- Approval Number
- 国药准字H20073969
- Approval Date
- Jan 5, 2022
NMPA
Sodium Ibandronate Injection
- Product Name
- 伊班膦酸钠注射液
- Approval Number
- 国药准字H20217088
- Approval Date
- Oct 15, 2021
NMPA
Trimetazidine Dihydrochloride
- Product Name
- 盐酸曲美他嗪
- Approval Number
- 国药准字H20056629
- Approval Date
- Apr 21, 2021
NMPA
Cinacalcet Hydrochloride Tablets
- Product Name
- 盐酸西那卡塞片
- Approval Number
- 国药准字H20213111
- Approval Date
- Feb 2, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found